Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Laurus Labs Ltd (LAUL)
The Laurus Labs share price today is 1,100.95, view NSE LAUL stock exchange data. Track the latest Laurus Labs share price with real-time updates on LAUL stock performance including market cap, day range, 52-week range and dividend yield. Access LAUL charts, earnings dates and analyst estimates to support your investment decisions.
1,100.95
-5.15(-0.47%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,080.00
1,112.95
52 wk Range
572.25
1,144.85
LAUL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,080.001,112.95
52 wk Range
572.251,144.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.18%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LAUL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
976.00
Downside
-11.35%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Laurus Labs Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
6 Buy
3 Hold
5 Sell
Ratings:
14 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 976.00
(-11.35% Downside)
Earnings
Latest Release
30-04-2026
EPS / Forecast
5.22 / 5.06
Revenue / Forecast
18.12B / 18.96B
Compare LAUL to Peers and Sector
Metrics to compare | LAUL | Peers Peers - average of corresponding metrics from companies closely matching LAUL: DIVISLAB, LUPIN, SAILIFE, SMSPHARMA, AARTIDRUGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLAULPeersSector |
|---|---|---|---|---|
P/E Ratio | 70.5x | 42.2x | −0.5x | |
PEG Ratio | - | 1.38 | 0.00 | |
Price/Book | 11.2x | 5.2x | 2.6x | |
Price / LTM Sales | 8.8x | 5.0x | 3.2x | |
Upside (Analyst Target) | −5.3% | 11.7% | 48.1% | |
Fair Value Upside | Unlock | 0.4% | 6.6% | Unlock |
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Laurus Labs (LAUL) Share Price Today?
The Laurus Labs share price today is 1,100.95.
What is the current Laurus Labs (LAUL) share price and day range?
As of 03-05-2026, the Laurus Labs share price is 1,100.95, with a previous close of 1,106.10. The share price has ranged from 1,080.00 to 1,112.95 today, while the 52-week range spans from 572.25 to 1,144.85.
What Is the Laurus Labs Market Cap?
As of today, Laurus Labs market cap is 594.36B.
Does Laurus Labs Pay Dividends? What's The Current Dividend Yield?
The Laurus Labs dividend yield is 0.18%.
What Is the Laurus Labs (LAUL) Share Price Target?
The average 12-month share price target for Laurus Labs is 976.00, with a high estimate of 1270 and a low estimate of 510. 6 analysts recommend buying, while 5 suggest selling, with an overall rating of Neutral and -11.35% Downside potential.
What Is Laurus Labs's Earnings Per Share (TTM)?
The Laurus Labs EPS (TTM) is 15.61.
When Is the Next Laurus Labs Earnings Date?
Laurus Labs will release its next earnings report on 23-07-2026.
From a Technical Analysis Perspective, Is LAUL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Laurus Labs Trade On?
Laurus Labs is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Laurus Labs?
The stock symbol for Laurus Labs is "LAUL."
How Many Times Has Laurus Labs Stock Split?
Laurus Labs has split 1 times.
How Many Employees Does Laurus Labs Have?
Laurus Labs has 6167 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.